Changes in the androgen levels in asthmatic men may be associated with the severity of asthma. Androgens induce a nongenomic relaxation in airway smooth muscle, but the underlying mechanisms remain unclear. The aim of this study was to investigate the potential bronchorelaxing action of testosterone (TES) and its metabolites (5a-and 5b-dihydrotestosterone (DHT). A preventive effect on ovalbumin (OVA)-induced bronchospasm was observed in sensitized guinea pigs for each androgen. Androgens were studied in response to bronchoconstrictors: carbachol (CCh) and KCl in isolated trachea rings with and without epithelium from non-sensitized and sensitized animals as well as on OVA-induced contraction. Androgens concentration-dependently abolished the contraction in response to CCh, KCl, and OVA. There were significant differences in the sensitivity to the relaxation induced by each androgen. 5b-DHT was more potent for relaxing KCl-induced contraction, while TES and 5a-DHT were more potent for CCh-and OVA-induced contraction. No differences were found in preparations with and without epithelium or in the presence of a nitric oxide (NO) synthase inhibitor or an inhibitor of K C channels. These data indicate the absence of involvement of the epithelium-, NO-and K C channels-dependent pathway in androgen-induced relaxation. However, in dissociated tracheal myocytes loaded with the calcium-binding fluorescent dye Fura -2, physiological concentrations of androgens decreased the KCl-induced [Ca 2C ] i increment. 5b-DHT was the most potent at decreasing KCl-induced [Ca 2C ] i increment and preventing bronchospasm. We suggest that androgen-induced brochorelaxation was mediated via decreased Ca 2C influx through L-type Ca 2C channels but additional Ca 2C entry blockade may be involved. Molecular changes in androgen structure may determine its preferential site of action.
Introduction
It is well know that asthma is a chronic disease that affects the airways and is responsible for substantial worldwide morbidity and mortality. An association between asthma and sex steroid hormones has been noticed. Clinical and epidemiological studies agree that before puberty, childhood asthma is more frequent in boys than in girls (Bonner 1984 , Ninan & Russell 1992 , Sears 1997 , Zannolli & Morgese 1997 The International Study of Asthma and Allergies in Childhood 1998 , Becklake & Kauffmann 1999 , Mutius & Martínez 1999 , Kjellman & Gustafsson 2000 , Osman 2003 , Townsend et al. 2012 , but following puberty, asthma is more prevalent among adult women and women exhibit a more severe form compared with men (Paoletti et al. 1995 , Becklake & Kauffmann 1999 , de Marco et al. 2000 , Osman 2003 , Melgert et al. 2007 , Postma 2007 , Almqvist et al. 2008 , Chen et al. 2008 , Jeon et al. 2009 ). Remarkably, asthma severity decreases during adolescence only among males. Likewise, it has been documented that the low testosterone (TES) levels in elderly men may exacerbate asthma, but additional studies are needed to determine the role, if any, of low TES levels in the risk of asthma. Nevertheless, taken together, these lines of evidence indicate that the difference in the disease may be associated with the sex hormones.
In general, it is accepted that female sex hormones (estrogens and progesterone) aggravate asthma and other allergic diseases, whereas male sex hormones (androgens) suppress such illness (Haggerty et al. 2003 , Osman 2003 , Townsend et al. 2012 , Ticconi et al. 2013 . Consequently, the available data indicate that androgens, indeed, play a major role in asthma, which might be associated with low TES level in childhood or deficiency in the aging male.
Steroid hormones elicit very rapid effects that are not mediated by the classic intracellular steroid receptors (nongenomic mechanism). This effect of steroids on airway smooth muscle (ASM) has been scantily examined. We have previously demonstrated that progesterone and its immediate 5b-reduced metabolite, pregnanolone, induce a nongenomic relaxation of guinea pig trachea (Perusquía et al. 1997) . Likewise, estrogens have also been reported to be nongenomic relaxants (Townsend et al. 2010 (Townsend et al. , 2012 . Little attention has also been paid to the effect of androgens on ASM, only three basic research studies have examined this issue. Using male rabbit tracheal strips, it was found that TES and TES-BSA induce a slight relaxation on the acetylcholine-induced contraction which seems to be partially mediated through epithelium and nitric oxide (NO; Kouloumenta et al. 2006) . Similarly, in male guinea pig and bovine tracheal rings and strips, the 5a-reduced metabolite of TES, 5a-dihydrotestosterone (5a-DHT), produces substantial nongenomic relaxation on carbachol (CCh)-and KClinduced contraction (Bordallo et al. 2008) ; these relaxations are epithelium independent, contrasting with the study of Kouloumenta et al. (2006) . In addition, Bordallo et al. (2008) also found the first clue that the relaxant effect elicited by 5a-DHT might be attributed to voltage-gated L-type Ca 2C channel blockade. Indeed, the findings of these two pioneer studies have revealed that androgeninduced relaxation on ASM is nongenomically mediated, but the role of epithelium is yet unclear, and the limited in vitro data do not provide any solid indication about the site of the relaxing action of androgens. Recently, our group has provided evidence that the precursor of these androgens, DHEA, is also capable of inducing a nongenomic epithelium-independent relaxation of the ASM of male guinea pigs. DHEA also prevents the bronchospasm induced by ovalbumin (OVA) in sensitized guinea pigs; an effect produced directly by DHEA and not after its bioconversion into TES or estrogens. Moreover, our data indicated that DHEA-induced ASM relaxation may involve, at least in part, a blockade of voltage-dependent Ca 2C channels (Espinoza et al. 2013) .
Contraction of ASM is considered to be an important pathway leading to the manifestation of asthmatic symptoms. Obviously, the role of androgens in the regulation of airway contractile action, by inducing relaxation, is of considerable importance and merits continued investigation. In this context, our study was designed to explore the direct action of TES and its 5-reduced metabolites on a guinea pig model of allergic asthma. The preventive effect of TES, 5a-DHT or 5b-DHT, on the bronchospasm induced by OVA in guinea pigs was examined using anesthetized whole-body plethysmography. Of particular interest was comparison of the in vitro relaxation effects of androgens on the KCl-, CCh-, or OVA-induced tracheal smooth muscle contraction in non-sensitized and sensitized guinea pigs. In addition, we also studied the role of i) epithelium, under controlled conditions that ensured the removal of epithelium and ii) K C channels in the androgen-induced relaxation of ASM. Likewise, in order to shed further light on the mechanism of action of androgen-caused relaxation, additional experiments were carried out using single ASM cells to examine whether androgens may affect KCl-induced intracellular Ca 2C increment. 
OVA-sensitization procedure
To obtain the animal model of allergic asthma, guinea pigs were sensitized at day 1 by administration of 0.5 ml i.p. and 0.5 ml s.c. 60 mg/ml OVA and 1 mg/ml Al(OH) 3 (as adjuvant) dissolved in saline (0.9% NaCl). At day 8, the animals received an antigenic challenge with 3 mg/ml OVA in saline solution nebulized during 5 min, delivered by an ultrasonic nebulizer (WH-2000; Medical Instrument Factory Co. Ltd, Guangdong, China). On day 15, animals received another antigenic challenge with 1 mg/ml OVA in saline solution nebulized for 1 min. The response to antigen was always established by deep abdominal breathing. Thus, only guinea pigs with increased dyspnea were selected for this study. Finally, the guinea pigs were subjected to experimentation at days 21-25.
Androgen effect on OVA-induced bronchospasm
Lung resistance (R L ) was measured by using the isovolumetric method in a closed-chamber plethysmograph (Buxco Electronics, Inc., Wilmington, NC, USA 50 (androgen dose to prevent 50% of bronchospasm) and E max (maximal prevention of bronchospasm by androgen) were obtained from the dose-response curves. Only one dose was administrated to each animal. Guinea pigs with a poor response to antigen were discarded from the study.
Tracheal rings preparation and contractile force measurements in vitro
In order to compare the effect of androgens on healthy (control group) and treated (sensitized group) guinea pigs, we used the same experimental protocol for the two groups. Guinea pigs were deeply anaesthetized with sodium pentobarbital (35 mg/kg, i.p.) and then killed by exsanguination. The trachea was immediately placed in KrebsHenseleit bicarbonate solution (KHS) with the following composition (mM): NaHCO 3 (25), NaCl (120), KCl (4.7), KH 2 PO 4 (1.2), MgSO 4 (1.2), CaCl 2 (2.5), and glucose (11.0); aerated continuously with a gas mixture of 95% O 2 and 5% CO 2 to maintain pH 7.4 and the temperature set at 37 8C. The trachea was cut into eight tracheal rings of w0.3 cm of length (each one containing three cartilaginous rings).
To determine the role of the epithelium in the relaxing effect induced by each androgen, tracheal rings from non-sensitized and sensitized animals were used in two ways: i) preparations with epithelium, tracheas were carefully handled to avoid injuring the epithelium and ii) preparations without epithelium which were produced by vigorously rubbing the luminal surface of tracheal rings using a dental drill bur with cylinder round end (K-File Colorinox 140 (Dentsply, York, PA, USA)). The presence and absence of epithelium were evaluated functionally in all experiments. Briefly, each tracheal ring was suspended horizontally between two stainless steel wires, and placed in an organ bath containing 10 ml KHS continuously supplied with O 2 :CO 2 95:5 throughout the experiment for recording isometric tension. One wire was attached to a fixed support at the bottom of the chamber and the other end to an isometric force transducer (FTO3C; Grass Instrument, Quincy, MA, USA) connected to a computerized data acquisition and analysis system (MP 150; Biopac Systems, Santa Barbara, CA, USA). The resting force was adjusted to 10 mN (1 g). Under these conditions, the tissues were equilibrated for 1 h before the experiments were conducted. Then, the contractile responses to 60 mM KCl were induced after replacing KHS with an equimolar quantity of 60 mM KCl and 64.7 mM NaCl. KCl caused a tonic contraction, which was repeated three times in order to verify the reproducibility of the response and to determine the maximum stable tonic contraction during 15 min. After each KCl stimulus, the tissues were washed with KHS to re-equilibrate them for 60 min.
The epithelial condition was pharmacologically corroborated as reported previously (Bramley et al. 1990 ). Bradykinin (BK) induces epithelium-dependent relaxation; on this basis, 320 nM BK was added to each preparation at basal tone. When the response to BK was observed, the tissues were washed with KHS.
Androgen response on pre-contracted ASM
Tissues were made to contract by the addition of different agents (KCl, CCh, or OVA); these contractions were stable with constant amplitude for a long time (recorded during more than 2 h). After a stable tension was attained (w15 min), different concentrations (9, 20, 42, 91 , and 200 mM) of TES, 5a-DHT or 5b-DHT, dissolved in absolute ethanol, were added cumulatively with an interval of 15 min between each addition. Subsequently, the tissues were washed with KHS to allow them to re-equilibrate for 60 min before inducing the last contraction with KCl or CCh, and these contractions were recorded over 90 min (second control response to verify tissue viability). This was not the case for OVA-induced contraction, which never returned to the baseline after washout. The concentrationresponse curves for each androgen were plotted, and the inhibitory concentration 50 (IC 50 ; androgen concentration that inhibited 50% of KCl-, CCh-, or OVA-induced contraction) was calculated to compare the potency of each androgen and the sensitivity of each contraction to androgen-induced relaxation. Likewise, the highest percentage of inhibition, i.e. the maximal relaxing effect (E max ) on KCl-, CCh-, or OVA-induced contraction, was obtained for each androgen to determine their efficacy. In a separate group of experiments, the effect of the vehicle of androgens (ETOH; absolute ethanol) on the different tonic contractions was determined; each concentration added never exceeded 0.1% v/v. The cumulative concentration-response curves for each androgen on contractions induced by different agonists were determined independently for tracheal rings from different animals, expressed as meanGS.E.M. (nZ6, where nZ1 represents one guinea pig). The IC 50 and E max values for each group were compared among them.
The potential role of NO in the relaxing effect of androgens
The potential role of NO in androgen-induced relaxation was separately explored. Tracheal rings with epithelium from non-sensitized animals were incubated with the NO synthase inhibitor, N u -nitro-L-arginine methyl ester (L-NAME, 10 mM), for 30 min before the KCl-induced contraction, afterwards, the relaxation in response to the same cumulative concentrations of each androgen was measured. The relaxing effect of each androgen was observed over 30 min. The concentration-response curve for each androgen as well as their potency and efficacy was compared between tracheal preparations without and with the L-NAME pretreatment.
Possible interaction of androgens with K C channels
To analyze the possible interaction of androgens with K C channels, the relaxing effect of androgens was studied in the presence of tetraethylammonium (TEA); an inhibitor of the voltage-dependent K C channels (K v ) at low concentrations (%1 mM), and of the large-conductance Ca 2C -activated K C channels (BK Ca ) at higher concentrations (10-30 mM) in ASM (Campos-Bedolla et al. 2006) . On this basis, three different concentrations of TEA (1, 10, or 30 mM) were separately applied 30 min before the concentration-response curve for each androgen was determined for CCh-induced contraction. The results were compared with the concentration-response curve for each androgen without TEA pretreatment.
Measurement of intracellular Ca
2C concentration in guinea pig tracheal myocytes Guinea pig tracheal myocytes were obtained as previously reported (Flores-Soto et al. 2013) . The cells were loaded with 0.35 mM the calcium-binding fluorescent dye Fura-2-AM under low Ca 2C conditions (0.02 mM) at room temperature (22-25 8C) . After 1 h, cells were allowed to settle into a 1.5 ml heated perfusion chamber with a glass cover in the bottom. This chamber was mounted on a Nikon inverted microscope (Diaphot 200, Nikon, Tokyo, Japan) and the cells adhered to the glass were continuously perfused at a rate of 2-2.5 ml/min with KHS containing 2 mM Ca 2C (at 37 8C and pH 7.4 equilibrated with 5% CO 2 in O 2 ). The cells were exposed to alternating pulses of 340 and 380 nm excitation light, and light emitted at 510 nm was measured using a microphotometer (Photon Technology Intl, Princeton, NJ, USA). Background fluorescence was automatically subtracted and determined by removing the cell from the field before the experiments were started. The fluorescence acquisition rate was 0.5 s. Intracellular Ca 2C concentration ([Ca 2C ] i ) was calculated according to the formula of Grynkiewicz et al. (1985) . The K d of Fura-2-AM was assumed to be 224 nM. The mean 340:380 fluorescence ratios R max and R min were obtained as previously reported (Grynkiewicz et al. 1985) . Recordings were stored in a microcomputer and evaluated using a data acquisition and analysis software (Felix, version 1.21, Photon Technology Intl).
To evaluate the effect of the androgens on the [Ca 2C ] i , single myocytes were stimulated with 60 mM KCl (equimolar) to raise [Ca 2C ] i , and this response was considered the control. Afterward, the cells were perfused with KHS for 15 min. Immediately, the cells were incubated for 5 min with noncumulative concentrations of each androgen (1, 10, 100, and 320 nM), dissolved in absolute ethanol (0.1% v/v), and stimulated again with 60 mM KCl for each concentration. Finally, cells were washed with KHS and a last 60 mM KCl stimulus was done to evaluate their viability. We verified that ethanol, the vehicle for androgen administration, did not modify the response to KCl. The effect of androgens was compared with the control response.
Statistical analysis
In the tension studies, all data in text and figures are expressed as a percentage of inhibition to the contraction induced by different agents (KCl, CCh, or OVA) and evaluated by comparing the amplitude of the contraction before (control 100%) and 15 min after the addition of each androgen concentration. Bronchospasm was expressed as changes in R L (% increase). Each experiment was carried out in individual guinea pigs (nZ6, where nZ1 represents one guinea pig). The non-paired Student's t-test was used to compare the response between two groups. The comparison between treatments and the control was done by one-way ANOVA followed by Dunnett's multiple comparison test. In the experiments with single cells, each experiment was carried out in individual cells (nR3 cells), a paired Student's t-test was used for comparison. To compare IC 50 , ED 50 , and E max between groups, a one-way ANOVA followed by Tukey's multiple comparisons test was used. Significance was accepted at P!0.05. Data presented in the text and figures are meanGS.E.M.
Drugs and chemicals
With exception of sodium pentobarbital (Anestesal; Pfizer, Mexico City, México), the remaining compounds were purchased from Sigma and included the following: TES (17b-hydroxy-4-andosten-3-one), 5a-DHT (17b-hydroxy-5a-androstan-3-one), 5b-DHT (17b-hydroxy-5b-androstan-3-one), carbachol chloride, BK, OVA, aluminum hydroxide, and L-NAME. The androgens were separately prepared as stock solutions in absolute ethanol and then diluted in the same solvent to the concentrations needed for each experiment; 10 ml aliquots were added to the 10 ml bath chambers, which never exceeded 0.5% v/v of vehicle, and the remaining drugs were dissolved in distilled water. BK was kept in the dark until use in order to avoid light-induced degradation.
Results
Preventive effects of androgens against bronchospasm Figure 1A shows the time-course of change in R L after challenge with OVA in the sensitized guinea pigs. After 4 min of the challenge, an elevation of basal R L value to 3.80G0.54 cm H 2 O/ml per s (nZ6 animals) was observed as the maximal peak of bronchospasm (fast response (FR)), 12 min later this acute response ended but the basal R L value was not restored for more than 30 min (delayed response (DR)). The FR was delayed (w2 min) when each androgen was given intravenously and decreased (19-92%) in a dose-dependent manner. Furthermore, all androgens diminished (25-100%) the DR, which was completely abolished at the highest dose tested (Fig. 1A) . Figure 2B shows the percentages of prevention of the FR induced by each androgen; the order of potency was 5b-DHTOTESO5a-DHT. The same dose-volume of the androgen vehicle (40 ml DMSO) did not change the R L value after the antigen challenge. We observed that the bronchospasm prevention by androgens was not accompanied by significant changes in blood pressure and heart rate in any case (data not shown).
Androgen effect on ASM contraction
The three androgens tested were found to relax the contraction induced by contractile agents (KCl, CCh, and OVA) in a concentration-dependent manner (Fig. 2) . No significant differences (PO0.05) were found in the relaxation responses and potency elicited by androgens in non-sensitized and sensitized animals, vehicle (PO0.05) did not significantly change the tone of the contraction elicited by different agents. Clearly, the analysis of these curves (Fig. 2) indicated that the relaxant potency (IC 50 ) of 5b-DHT on KCl-induced contraction is significantly greater (P!0.01), 0.75 times more potent, than that of TES, and 0.58 times more potent than that of 5a-DHT. However, TES relaxes CCh-and OVA-induced contraction more potently than 5a-DHT and 5b-DHT (P!0.01), which were equipotent. The order of potency was i) for KClinduced contraction, 5b-DHTO5a-DHTOTES and ii) for CCh-and OVA-induced contraction, TESO5a-DHTR5b-DHT. Regarding the relaxant efficacy (E max ), the same efficacy was observed for 5b-DHT and TES on KCl-and CCh-induced contraction where 5a-DHT showed the least efficacy. Nevertheless, TES and 5a-DHT had equivalent efficacy for relaxing the OVA-induced contraction, but 5b-DHT was less efficient. All androgens were capable of abolishing completely the tone of the contractions elicited by different contractile agents (100% inhibition); notably, the different efficacies were obtained at the highest concentration tested (200 mM) where the androgens diminished the basal tone (O100% of inhibition; below baseline), see concentration-response curves (Fig. 2) .
In this study, the effects of presence or absence of epithelium were evaluated functionally in all experiments. Figure 3A shows that the presence of epithelium in the tracheal rings was confirmed when BK elicited a loss at the basal tone, and the absence of epithelium (rubbed preparations) was corroborated when BK increased the basal tone (R0.3 g). The relaxing effect of all androgens on KCl-or CChinduced contraction was not prevented when epithelium was removed. On the contrary, they had a greater relaxation (P!0.0001) in preparations without epithelium, which is represented by their different IC 50 values (Fig. 3B) . Likewise, the relaxing effect of androgens was studied in the absence and presence of the NOS-inhibitor, L-NAME. This drug did not change the relaxing effect of androgens (Fig. 3C) .
To explore the probable participation of K C channels in androgen-induced relaxation, we observed that pre-treatment with 1, 10, or 30 mM TEA did not modify the concentration-response curves to androgens of the CCh-induced contraction (Fig. 4) ] i (165-199 nM), which was reproducible after several KCl stimuli (control response, Fig. 5A ). The increment of [Ca 2C ] i induced by KCl was significantly diminished (P!0.05) in a concentration-dependent manner, when the cells were pre-incubated with TES or 5b-DHT ( Fig. 5B and D) . The results for 5a-DHT did not significantly differ from those for controls at any concentrations tested ] i increment and consequently, its IC 50 was not calculated (Fig. 5C ). The IC 50 for TES was 21.90G5.94 nM and for 5b-DHT was 6.06G3.90 nM. Notably, 5b-DHT was 2.61 times more potent than TES. The vehicle used to deliver the androgens did not significantly affect (PO0.05) the KCl-induced [Ca 2C ] i increment.
Discussion
Relaxation induced by TES and its five-reduced metabolites was examined in the present study. This is the first time, to our knowledge, that the relaxation induced by these androgens has been tested in an animal model of asthma.
Our study reveals that androgen-induced relaxation in vitro is active in vivo due to the acute prevention of the antigeninduced bronchospasm.
Bronchospasm prevention by androgens
As guinea pig models can provide some of the essential features of human asthma, we have established that the androgen-induced relaxation of isolated trachea of guinea pigs and rabbits (Kouloumenta et al. 2006 , Bordallo et al. 2008 ) is consistent with the results of the present in vivo studies, which is, to our knowledge, the first evidence of the bronchodilating effect elicited by androgens in an in vivo model of allergic asthma. Androgens actually diminished the bronchospasm induced by an antigenic challenge in guinea pigs sensitized with OVA. The preventative effect of androgens on FR demonstrated that their direct bronchorelaxing response is nongenomically mediated in ASM (Kouloumenta et al. 2006 , Bordallo et al. 2008 , Espinoza et al. 2013 . The ability of androgens to abolish the DR indicates their immunomodulating, and antiinflammatory genomically mediated effect (Cutolo 1997 , Dalal et al. 1997 , Malkin et al. 2004 , Corrales et al. 2006 , Traish et al. 2011 , Koziol-White et al. 2012 . This protective activity of androgens against a bronchospasm revealed the same order of potency as that observed in the in vitro experiments described below (5b-DHT exhibited major potency than TES and 5a-DHT). Therefore, the order of potency might mainly reside in its chemical structure.
Androgens relaxing mechanism
The magnitude of the relaxing effect of androgens in vitro was similar for tissues from non-sensitized and sensitized Contribution of the epithelium to androgen-induced relaxation in isolated tracheal preparations from guinea pigs. (A) Typical recording demonstrating that 320 nM bradykidin (BK) elicited a decrease in the basal tone in the unrubbed preparations with epithelial integrity (CE), and the absence of epithelium in the rubbed preparations (KE) was corroborated when BK increased the basal tone. After washout (W), the basal tone recovered.
(B) Androgen-induced relaxation was increased, but not prevented, in KE preparations; significant differences in the IC 50 value for each androgen were observed (*P!0.0001 and **P!0.000001), each bar represents the meanGS.E.M. (nZ6). (C) The nitric oxide synthase inhibitor (L-NAME, 10 mM) did not change the concentration-response curves of androgen-induced relaxation, nZ6GS.E.M.
animals, demonstrating that the pathological status might not be an important factor for the relaxing effect induced by androgens. The implication that androgens assayed induce relaxation of contractions induced by different contractile responses, including OVA-induced constriction in sensitized animals, deserves further consideration. Notably, KCl-induced contraction was more sensitive to 5b-DHT than to TES or 5a-DHT, implying a reduction in extracellular Ca 2C influx due to the blockade of the L-type voltage-operated Ca 2C channel (VOCC), strongly induced by 5b-DHT and moderately induced by 5a-DHT and TES. This finding was confirmed by the fact that the 5b-reduced androgen was the most potent for diminishing KClinduced [Ca 2C ] i increment in a single cell, in contrast to its 5a isomer which was weakly effective. Moreover, this important evidence categorically shows that androgens, indeed, are blocking the VOCC to diminish [Ca 2C ] i at nanomolar concentrations and might be even acting at plasmatic concentrations in adult men with TES ranges from 11 to 36 nmol/l. Remarkably, the single cells required much lower concentrations of the androgen than the isolated tissue, due to the fact that it was directly applied to a single tracheal cell.
In agreement with our data, previous observations during functional studies had indicated that the relaxing effect elicited by 5a-DHT (Bordallo et al. 2008) and DHEA (Espinoza et al. 2013) Perusquía & Stallone (2010) ). In contrast to KCl-induced contraction, the CCh-and OVA-induced contraction may involve mechanisms other than activation of VOCCs. Therefore, this implies that androgens induced relaxation by more complex processes. It is well known that the CCh-induced contraction has two phases: a rapid phasic contraction and a tonic sustained contraction. In guinea pig ASM, the first one mainly involves Ca 2C released from the sarcoplasmic reticulum, VOCC and store operated Ca 2C entry (SOCE; Flores-Soto et al. 2013 ) and the second probably involves VOCC, SOCE, and receptor-operated Ca 2C channels (ROCC). The outstanding ability to relax this kind of contraction of TES and 5a-DHT indicates that in addition to the blocking action on VOCC, these may be better blockers of the SOCE and ROCC than 5b-DHT. This evidence is consistent with the slight diminution on KCl-induced [Ca 2C ] i increment, particularly elicited by 5a-DHT and to a lesser extent by TES. In conclusion, our results indicate that the mechanisms of androgen-induced relaxation in ASM are at least partially mediated via blockade of SOCE and ROCC in addition to the blocking action on VOCC. Recently, we have found that DHEA elicited a complete relaxation of OVA-induced ASM contraction in guinea pig (Espinoza et al. 2013) . Because androgens tested in the present work also relax the OVA-induced contraction, they might be also acting in a similar way to that previously discussed for CCh. Nevertheless, it is important to highlight that each androgen may have a preferential site of action for inducing relaxation.
Regarding the role that the tracheal epithelium may play in androgen-induced relaxation, it has been reported that the absence of epithelium in isolated rabbit trachea 'attenuated' but did not abolish relaxing effect of TES, which indicated a partially epithelium-dependent mechanism (Kouloumenta et al. 2006) . In contrast, another study demonstrated an epithelium-independent mechanism for TES and its metabolites in guinea pig trachea (Bordallo et al. 2008) . These two studies have conflicting findings; in both works the authors did not show data verifying that the epithelium had been removed. We have observed that the tracheal epithelial layer in guinea pigs is not adequately removed when a cottontipped applicator is gently used as previously reported (Bordallo et al. 2008) ; thus, in our study the preparations were vigorously rubbed with a dental drill bur with cylinder round end to eliminate completely the epithelium, which was always pharmacologically confirmed. Our data clarified the role of epithelium under highly controlled conditions, i) androgen-induced relaxation was not prevented when the epithelium was removed and ii) epithelium removal caused a greater relaxing effect in response to androgen. These findings indicate that androgens act directly on the ASM cells, and that the mucosa, including epithelium, might be limiting the androgen diffusion to the ASM and/or that the epithelium-derived contracting factors might counteract the relaxing effect induced by androgens. In addition, the fact that L-NAME did not prevent the relaxing effect of androgens leads us to rule out the involvement of NO in the androgen action in guinea pig. These data disagree with the suggestion that TES induces relaxation in rabbit trachea via an epithelium-mediated mechanism (Kouloumenta et al. 2006) ; in view of that, the epithelial contribution may be species dependent.
Admittedly, androgens may open K C channels in ASM. TEA (1-30 mM) did not inhibit androgen-induced relaxation. Because TEA blocks K v and BK Ca, which are the most important K C channels in ASM (Montaño et al. 2011) , it can be concluded that they do not participate in the androgen-induced relaxation. In addition, the possibility that the b 2 -adrenoceptors are involved in the relaxation to 5a-DHT or DHEA (Bordallo et al. 2008 , Espinoza et al. 2013 , as well as the polyamine synthesis in the relaxation induced by 5a-DHT (Bordallo et al. 2008) , has been eliminated. The potency of each androgen for relaxing the different contractions might be dependent on its structural conformation and preferential site of action. Thus, the structural conformation of TES (D4-3ceto configuration) and 5a-DHT (5a-configuration) might display a preference for inactivating ROCC and SOCE. In contrast, 5b-DHT (5b-configuration) acquires a dramatic bend in its A-ring, which might result in preferential interaction with the VOCC, acting predominantly as a L-type Ca 2C blocker. Remarkably, it was clear that 5b-DHT is more efficacious at preventing contraction by inducing strong ASM relaxation, particularly on KCl-induced contraction, to diminish KCl-induced [Ca 2C ] i increment and to prevent bronchospasm. In this sense, the A-ring reduction in TES at the 5b position (5b-DHT) gives an optimal activity for preventing bronchospasm. This chemical structure-relaxing activity relationship is consistent with our previous studies, where progesterone (D4-3ceto configurated) and its 5-reduced metabolites (5a-progestin and 5b-progestin) have the same chemical structure-relaxing activity relationship in isolated guinea pig trachea. 5b-Progestin exhibited more potent relaxation than progesterone, and 5a-progestin displayed the lowest potency (Perusquía et al. 1997) . Likewise, we have reported that 5a-DHT exhibits a lower efficacy and/or potency than TES for inducing vascular (Perusquía et al. 2007 , Perusquía & Stallone 2010 and uterine (Perusquía 2001 , Perusquía et al. 2005 relaxation, but 5b-DHT is markedly more potent than TES. Taken together, our findings indicate that the mechanism of action of androgeninduced relaxation are dependent on different molecular structures and cannot be generalized and/or established when only one type of androgen has been studied.
Physiological and clinical relevance
In men, severity of asthma is relatively stable from puberty until later in life (e.g. !50 years), when decreasing serum TES levels may contribute to increasing the severity of this illness (Zannolli & Morgese 1997 , Canguven & Albayrak 2011 . As androgens can modulate pulmonary inflammatory processes (da Silva 1999, Yu et al. 1999 , Kasperska-Zajac 2010 , Koziol-White et al. 2012 and ASM function by inducing bronchorelaxation (this study), these properties indicate that they are bronchobioactive drugs, and thereby may play a relevant role in the occurrence of asthma. It is important to take into account the fact that androgen metabolism has been shown in airways; for instance, in alveolar macrophages with conversion of androstenedione into TES and 5a-DHT (Milewich et al. 1983 ) and perhaps into its 5b isomer.
In this context, androgen deficiency may be considered at least partly accountable for asthma symptoms. This suggestion correlates well with an early clinical study. TES (10 mg/day for 5 days) was found to improve symptoms in 88% of women suffering from premenstrual asthma (Wulfsohn et al. 1964) . Female patients suffering from status asthmaticus found rapid, acute relief (within 20 min) with a combined TES-gonadotropin injection (12.5 mg, 500 IU respectively) (Wulfsohn et al. 1964) . Although these limited data are from an old study, they do indicate that increased androgen levels may be beneficial in both males and females. Therefore, androgen replacement therapy after middle age to prevent or attenuate asthma symptoms may be considered in men. However, the virilizing effects of androgens, particularly of TES and 5a-DHT in females, and their implication in the genesis of prostatic cancer in males are an obvious concern and a recognized limitation. Nevertheless, 5b-DHT is an excellent alternative for treating asthma in men and women due to its good action as antibronchospasmodic. Moreover, 5b-DHT possesses several qualities: it is a nonaromatizable androgen, thus without estrogenic effects, and has no affinity for the androgen receptor and is devoid of androgenic actions, theoretically without virilizing or, estrogenic effects, there is no possibility of induction of prostatic cancer.
